Julia Salas Case Study, CS379a

Slides:



Advertisements
Similar presentations
Developing & Benchmarking Large-scale Docking (LSD) Pipeline Niu Huang, 02/17/2004.
Advertisements

Bioinformatics Vol. 21 no (Pages ) Reporter: Yu Lun Kuo (D )
Ubiquinase Johnny has a genetic disorder which leads to overactivity of the enzyme ubiquinase. Previous studies have determined 1) The molecule benzamide.
Background Goals Methods Results Conclusions Implications.
Two Examples of Docking Algorithms With thanks to Maria Teresa Gil Lucientes.
FLEX* - REVIEW.
BL5203: Molecular Recognition & Interaction Lecture 5: Drug Design Methods Ligand-Protein Docking (Part I) Prof. Chen Yu Zong Tel:
Molecular Docking Using GOLD Tommi Suvitaival Seppo Virtanen S Basics for Biosystems of the Cell Fall 2006.
Protein-protein and Protein- ligand Docking The geometric filtering.
Design of a novel globular protein with atomic-level accuracy.
Protein Structure and Drug Discovery Workshop To be held at Monash University, Mebourne, Australia October 3 rd to 4 th 2006 Molecular Visualization Learn.
LSM2104/CZ2251 Essential Bioinformatics and Biocomputing Essential Bioinformatics and Biocomputing Protein Structure and Visualization (3) Chen Yu Zong.
The Geometry of Biomolecular Solvation 1. Hydrophobicity Patrice Koehl Computer Science and Genome Center
Inverse Kinematics for Molecular World Sadia Malik April 18, 2002 CS 395T U.T. Austin.
Protein Structure Computation Gwyn Skone OUCL PRG Student Conference 2006.
BIOC3010: Bioinformatics - Revision lecture Dr. Andrew C.R. Martin
B. Signal Transduction Pathway (cell signaling)
MLRS 242 Immunology Pat Reed Antibodies
Flexible Multi-scale Fitting of Atomic Structures into Low- resolution Electron Density Maps with Elastic Network Normal Mode Analysis Tama, Miyashita,
SimBioSys Inc.© Slide #1 Enrichment and cross-validation studies of the eHiTS high throughput screening software package.
SimBioSys Inc.© 2004http:// Conformational sampling in protein-ligand complex environment Zsolt Zsoldos SimBioSys Inc., © 2004 Contents:
Altman et al. JACS 2008, Presented By Swati Jain.
Rational Drug Design : HIV Integrase. A process for drug design which bases the design of the drug upon the structure of its protein target. 1.Structural.
Virtual Screening C371 Fall INTRODUCTION Virtual screening – Computational or in silico analog of biological screening –Score, rank, and/or filter.
Enzymes.
BREED: Generating Novel Inhibitors through Hybridization of Known Ligands (A. C. Pierce, G. Rao, and G. W. Bemis) Richard S. L. Stein CS 379a February.
GRIDP: Web-enabled Drug Discovery Is there any way I can use computational tools to reduce the number of molecules I have to screen to a manageable number,
Surflex: Fully Automatic Flexible Molecular Docking Using a Molecular Similarity-Based Search Engine Ajay N. Jain UCSF Cancer Research Institute and Comprehensive.
Protein-Protein Interactions. A Protein may interact with: –Other proteins –Nucleic Acids –Small molecules Protein Interactions.
Effect of inhibitor binding on the 1H-15N HSQC spectra of RGS4.
Simplified picture of the principles used for multiple copy simultaneous search (MCSS) and for computational combinatorial ligand design (CCLD). Simplified.
Intracellular Pathogens Extracellular Pathogens
DATA MINING FOR SMALL MOLECULE ALLOSTERIC INHIBITORS
Chapter 5 Cell Signaling.
Drug Affinity Responsive Target Stability (DARTS).
Remember the Chapters 4 and 5 Test is on Monday
Communication within Multicellular Organisms
Predicting Active Site Residue Annotations in the Pfam Database
Virtual Screening.
“Structure Based Drug Design for Antidiabetics”
Cell Communication (1.4) – Part 1
Cell Communication.
Ligand Docking to MHC Class I Molecules
Enzymes.
Enzymes.
Serine proteases have a reactive serine
An Integrated Approach to Protein-Protein Docking
Note the effect of cooperativity in the example below.
Mechanisms of myocardial reperfusion injury
AnchorDock: Blind and Flexible Anchor-Driven Peptide Docking
Structure-based drug design: progress, results and challenges
Reporter: Yu Lun Kuo (D )
Protein structure prediction.
Joe G. Greener, Ioannis Filippis, Michael J.E. Sternberg  Structure 
Geometry-Based Sampling of Conformational Transitions in Proteins
György Abrusán, Joseph A. Marsh  Cell Reports 
Accounting for side-chain flexibility in protein-ligand docking: 3D Interaction Homology as an approach of quantifying side-chain flexibility of Tyrosine.
Approaches to solving the rigid receptor problem by identifying a minimal set of flexible residues during ligand docking1  Amy C Anderson, Robert H O’Neil,
Dynamics of Nuclear Receptor Helix-12 Switch of Transcription Activation by Modeling Time-Resolved Fluorescence Anisotropy Decays  Mariana R.B. Batista,
Volume 9, Issue 1, Pages (January 2002)
SBI 4U: Metablic Processes
Predicting Allosteric Changes from Conformational Ensembles
Targets for drug action
Mr.Halavath Ramesh 16-MCH-001 Dept. of Chemistry Loyola College University of Madras-Chennai.
Mr.Halavath Ramesh 16-MCH-001 Dept. of Chemistry Loyola College University of Madras-Chennai.
Mr.Halavath Ramesh 16-MCH-001 Dept. of Chemistry Loyola College University of Madras-Chennai.
Mr.Halavath Ramesh 16-MCH-001 Dept. of Chemistry Loyola College University of Madras-Chennai.
Research Rational Drug Design: A process for drug design which bases the design of the drug upon the structure of its protein target. Structural mapping.
Presentation transcript:

Julia Salas Case Study, 3-14-06 CS379a Crystallographically determined 1. Holo: Complexed conformation Apo: Uncomplexed conformation (Homology) Modeled Julia Salas Case Study, 3-14-06 CS379a

Introduction Docking often uses a single receptor structure Some algorithms allow for reception flexibility but at high cost For many targets, many structures are available Most proteins don’t have published structures 5,500 out of 730,000 with known sequence (2003) 10 enzymes with known holo, apo, and homology structures MDL Drug Data Report database molecules docked 95,000 compounds…known ligands between 0.3-1% DOCK3.5 used, ligands were allowed flexibility Enrichment factor was measured and compared (# of known ligands found in ranked list) / (# expected to be found randomly) What is the influence of protein structure on docking success? How good does a receptor structure have to be for successful docking?

Results Limitations of each type of target structure: In general, success of docking was best for holo followed by apo and lastly by modeled targets Limitations of each type of target structure: Holo (Best in 7 systems) Overspecialization Ligands with very different binding geometries were not well docked Apo (Best in 2 systems) Structure may be very different from ligand-bound structure Modeled (Best in 1 system) Sidechains could be poorly placed Holo Active Site Docked in Holo Apo Active Site Docked in Apo EXAMPLE: Thrombin (a Serine Protease) Apo was the best structure (24-fold over random): Slightly larger site Holo had at best 19-fold over random: Misses some H-bonds, restricted structure

Conclusions Nearly all structures led to enrichment Enrichment of at least 20-fold: 8 holo, 2 apo, 3 modeled Holo structures are most likely to lead to useful enrichment Except: Overspecialized Holo structures “Promiscuous” structures are the best targets Flexibility allowances in binding pocket lead to more accurate results Take into account the best of both the Holo and Apo structures